Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592539 · ClinicalTrials.gov registry record
Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 78
- Enrollment target
NCT01592539 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 78 participants.
The verdict
NCT01592539 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
The effects of high serum glucose on bone could be direct or could be indirect through its effects on the microvasculature. Previous studies by Rendell et al and Brugler et al have found significant differences in skin blood flow between diabetics and control. The investigators are proposing that blood flow measurements of the skin may be correlated with bone remodeling rates in iliac bone biopsies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01592539
The ClinicalTrials.gov registry entry for NCT01592539 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01592539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01592539 about?
NCT01592539 is a clinical study titled "Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls". The effects of high serum glucose on bone could be direct or could be indirect through its effects on the microvasculature. Previous studies by Rendell et al and Brugler et al have found significant differences in skin blood flow between diabetics and control. The investigators are proposing that bl...
What is the current status of trial NCT01592539?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2012-05. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT01592539?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.